Skip to Main Content

++

INTRODUCTION

++

bepotastine (be-poe-tass-teen)

Bepreve

Classification

Therapeutic: ocular agents

Pharmacologic: antihistamines

++
Indications
++

Treatment of itching associated with allergic conjunctivitis.

++
Action
++

Acts as a histamine H1 receptor antagonist; also inhibits the release of histamine from mast cells; does not bind to or inactivate histamine. Therapeutic Effects: Decreased ocular itching associated with allergic conjunctivitis.

++
Adverse Reactions/Side Effects
++

CNS: headache. EENT: nasopharyngitis. GI: taste in mouth following instillation.

++

PHYSICAL THERAPY IMPLICATIONS

++
Examination and Evaluation
++

  • Monitor eye pain, itching, and inflammation to help document whether drug therapy is successful in resolving allergic conjunctivitis.

++
Patient/Client-Related Instruction
++

  • Check that the patient and family or caregivers understand ophthalmic application procedures and adhere to the recommended dosing schedule.

  • Instruct patient and family/caregivers to report other troublesome side effects such as severe or prolonged headache, altered taste, or inflammation of the nose and pharynx.

++
Pharmacokinetics
++

Absorption: Some systemic absorption follows ophthalmic administration.

++

Distribution: Unknown

++

Metabolism and Excretion: Minimally metabolized by the liver; 75–90% excreted unchanged in urine

++

Half-life: Unknown

++

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print

TIME/ACTION PROFILE (antihistaminic activity)

ROUTE ONSET PEAK DURATION
ophthalmic within 15 min 1–2 hr* 12 hr

*Blood levels.

++
Contraindications/Precautions
++

Contraindicated in: Hypersensitivity.

++

Use Cautiously in: Contact lens use OB: Use during pregnancy if potential maternal benefit justifies the potential risk to fetus; Lactation: Use cautiously during breastfeeding; Pedi: Safe and effective use in children <2 yr has not been established.

++
Interactions
++

Drug-Drug: None noted

++
Route/Dosage
++

Ophthalmic (Adults): 1 drop in affected eye(s) twice daily.

++
Availability
++

Ophthalmic solution: 1.5%

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.